Deep Inspiration Breath Hold in Left-Sided Breast Radiotherapy: A Balance Between Side Effects and Costs

Overview

Journal JACC CardioOncol

Specialty Cardiology & Vascular Diseases

Date 2024 Sep 6

PMID 39239337

Authors

Sara-Lise Busschaert

Eva Kimpe

Thierry Gevaert

Mark De Ridder

Koen Putman

Affiliations

Soon will be listed here.

Abstract

Background: Deep inspiration breath hold (DIBH) is an effective technique for reducing heart exposure during radiotherapy for left-sided breast cancer. Despite its benefits, cost considerations and its impact on workflow remain significant barriers to widespread adoption.

Objectives: This study aimed to assess the cost-effectiveness of DIBH and compare its operational, financial, and clinical outcomes with free breathing (FB) in breast cancer treatment.

Methods: Treatment plans for 100 patients with left-sided breast cancer were generated using both DIBH and FB techniques. Dosimetric data, including the average mean heart dose, were calculated for each technique and used to estimate the cardiotoxicity of radiotherapy. A state-transition microsimulation model based on SCORE2 (Systematic Coronary Risk Evaluation) algorithms projected the effects of DIBH on cardiovascular outcomes and quality-adjusted life-years (QALYs). Costs were calculated from a provider perspective using time-driven activity-based costing, applying a willingness-to-pay threshold of €40,000 for cost-effectiveness assessment. A discrete event simulation model assessed the impacts of DIBH vs FB on throughput and waiting times in the radiotherapy workflow.

Results: In the base case scenario, DIBH was associated with an absolute risk reduction of 1.72% (95% CI: 1.67%-1.76%) in total cardiovascular events and 0.69% (95% CI: 0.67%-0.72%) in fatal cardiovascular events over 20 years. Additionally, DIBH was estimated to provide an incremental 0.04 QALYs (95% CI: 0.05-0.05) per left-sided breast cancer patient over the same time period. However, DIBH increased treatment times, reducing maximum achievable throughput by 12.48% (95% CI: 12.36%-12.75%) and increasing costs by €617 per left-sided breast cancer patient (95% CI: €615-€619). The incremental cost-effectiveness ratio was €14,023 per QALY.

Conclusions: Despite time investments, DIBH is cost-effective in the Belgian population. The growing adoption of DIBH may benefit long-term cardiovascular health in breast cancer survivors.

Citing Articles

Deep Inspiration Breath Hold to Reduce Cardiovascular Disease Risk for Breast Radiotherapy: Challenges and Opportunities.

Gao S, Zhang J, Hui B, Hu W, Lu Y JACC CardioOncol. 2025; 6(6):985.

PMID: 39801653 PMC: 11712011. DOI: 10.1016/j.jaccao.2024.08.009.

Reply: Deep Inspiration Breath Hold to Reduce Cardiovascular Disease Risk for Breast Radiotherapy: Challenges and Opportunities.

Busschaert S, Kimpe E, Gevaert T, De Ridder M, Putman K JACC CardioOncol. 2025; 6(6):986.

PMID: 39801637 PMC: 11711800. DOI: 10.1016/j.jaccao.2024.10.002.

Heart is a heavy burden: cardiac toxicity in radiation oncology.

Pouvreau P, Taleb I, Fontaine A, Edouard L, Gibson N, Yaouanq M Support Care Cancer. 2024; 32(11):769.

PMID: 39495349 DOI: 10.1007/s00520-024-08949-7.

References

Darby S, McGale P, Taylor C, Peto R . Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005; 6(8):557-65. DOI: 10.1016/S1470-2045(05)70251-5. View

Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M . Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011; 378(9804):1707-16. PMC: 3254252. DOI: 10.1016/S0140-6736(11)61629-2. View

Macrie B, Donnelly E, Hayes J, Gopalakrishnan M, Philip R, Reczek J . A cost-effective technique for cardiac sparing with deep inspiration-breath hold (DIBH). Phys Med. 2015; 31(7):733-7. DOI: 10.1016/j.ejmp.2015.06.006. View

Newman L, Kuerer H . Advances in breast conservation therapy. J Clin Oncol. 2005; 23(8):1685-97. DOI: 10.1200/JCO.2005.09.046. View

. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J. 2021; 42(25):2455-2467. PMC: 8248997. DOI: 10.1093/eurheartj/ehab312. View

Sardar P, Kundu A, Chatterjee S, Nohria A, Nairooz R, Bangalore S . Long-term cardiovascular mortality after radiotherapy for breast cancer: A systematic review and meta-analysis. Clin Cardiol. 2017; 40(2):73-81. PMC: 6490535. DOI: 10.1002/clc.22631. View

Conroy R, Pyorala K, Fitzgerald A, Sans S, Menotti A, De Backer G . Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003; 24(11):987-1003. DOI: 10.1016/s0195-668x(03)00114-3. View

Bartlett F, Colgan R, Donovan E, Carr K, Landeg S, Clements N . Voluntary breath-hold technique for reducing heart dose in left breast radiotherapy. J Vis Exp. 2014; (89). PMC: 4211647. DOI: 10.3791/51578. View

Lu Y, Yang D, Zhang X, Teng Y, Yuan W, Zhang Y . Comparison of Deep Inspiration Breath Hold Versus Free Breathing in Radiotherapy for Left Sided Breast Cancer. Front Oncol. 2022; 12:845037. PMC: 9069140. DOI: 10.3389/fonc.2022.845037. View

10.

Austin A, Douglass M, Nguyen G, Cunningham L, Le H, Hu Y . Individualised selection of left-sided breast cancer patients for proton therapy based on cost-effectiveness. J Med Radiat Sci. 2020; 68(1):44-51. PMC: 7890920. DOI: 10.1002/jmrs.416. View

11.

Abdel-Qadir H, Austin P, Lee D, Amir E, Tu J, Thavendiranathan P . A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer. JAMA Cardiol. 2016; 2(1):88-93. DOI: 10.1001/jamacardio.2016.3841. View

12.

Keel G, Savage C, Rafiq M, Mazzocato P . Time-driven activity-based costing in health care: A systematic review of the literature. Health Policy. 2017; 121(7):755-763. DOI: 10.1016/j.healthpol.2017.04.013. View

13.

Duma M, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R . Heart-sparing radiotherapy techniques in breast cancer patients: a recommendation of the breast cancer expert panel of the German society of radiation oncology (DEGRO). Strahlenther Onkol. 2019; 195(10):861-871. DOI: 10.1007/s00066-019-01495-w. View

14.

Pockett R, McEwan P, Ray J, Tran I, Shutler S, Martin S . Prospective utility study of patients with multiple cardiovascular events. J Med Econ. 2018; 21(6):616-621. DOI: 10.1080/13696998.2018.1454453. View

15.

. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021; 42(25):2439-2454. PMC: 8248998. DOI: 10.1093/eurheartj/ehab309. View

16.

. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet. 2000; 355(9217):1757-70. View

17.

Ferini G, Valenti V, Viola A, Umana G, Martorana E . A Critical Overview of Predictors of Heart Sparing by Deep-Inspiration-Breath-Hold Irradiation in Left-Sided Breast Cancer Patients. Cancers (Basel). 2022; 14(14). PMC: 9319386. DOI: 10.3390/cancers14143477. View

18.

Doege D, Thong M, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B . Health-related quality of life in long-term disease-free breast cancer survivors versus female population controls in Germany. Breast Cancer Res Treat. 2019; 175(2):499-510. DOI: 10.1007/s10549-019-05188-x. View

19.

Siebert U, Alagoz O, Bayoumi A, Jahn B, Owens D, Cohen D . State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3. Med Decis Making. 2012; 32(5):690-700. DOI: 10.1177/0272989X12455463. View

20.

Florescu D, Nistor D . Therapy-induced cardiotoxicity in breast cancer patients: a well-known yet unresolved problem. Discoveries (Craiova). 2020; 7(1):e89. PMC: 7093073. DOI: 10.15190/d.2019.2. View